Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancin-Reference-Cited by-同舟云学术

Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancin

Published:2023-05-31 Issue:7 Volume:21 Page:703-721
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Oliva Alessandra¹^ORCID,Carbonara Sergio²,Cianci Vito³,Crapis Massimo⁴,Di Domenico Enea Gino⁵,Falcone Marco⁶^ORCID,Galardo Gioacchino⁷,Durante-Mangoni Emanuele⁸⁹^ORCID,Venditti Mario¹^ORCID

Affiliation:

1. Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy

2. Infectious Diseases Department, V. Emanuele II Hospital, Bisceglie (BT), Italy

3. Department of Emergency, University Hospital of Padua, Padua, Italy

4. Department of Infectious Diseases, Santa Maria degli Angeli Hospital Pordenone, Pordenone, Friuli-Venezia Giulia, Italy

5. Department of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, Rome, Italy

6. Department of Clinical and Experimental Medicine, Infectious Diseases Unit, University of Pisa, Pisa, Italy

7. Medical Emergency Unit, Sapienza University of Rome, Rome, Italy

8. Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, Napoli, Italy

9. Unit of Infectious & Transplant Medicine, AORN Ospedali dei Colli-Monaldi Hospital, Napoli, Italy

Funder

This work was supported by an unrestricted grant from Angelini Pharma

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2023.2214727

Reference134 articles.

1. Current trends in the real-life use of dalbavancin: report of a study panel

2. Costs and Consequences Associated With Misdiagnosed Lower Extremity Cellulitis

3. Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis

4. Emergency department care of ABSSSI with dalbavancin infusion, direct discharge, and outpatient telemedicine follow up: a study protocol

5. Clinical pathway for moderate to severe acute bacterial skin and skin structure infections from a US perspective: a roundtable discussion

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Place in therapy of dalbavancin to treat Gram-positive infections in antimicrobial resistance era: an overview;Global and Regional Health Technology Assessment;2024-07-29

2. Usefulness of dalbavancin in early discharge and non-hospitalization. It’s time to throw your heart over the obstacle?;Global and Regional Health Technology Assessment;2024-07-29

3. The efficacy of dalbavancin and impact on hospitalization and treatment costs in patients with ABSSSI;Global and Regional Health Technology Assessment;2024-07-29

4. Prescriptive appropriateness of dalbavancin in acute bacterial skin and skin structure infections in adults: an integrated approach between clinical profile, patient- and health system-related factors and focus on environmental impact;Frontiers in Antibiotics;2024-04-24

5. Invasive Candida infection: epidemiology, clinical and therapeutic aspects of an evolving disease and the role of rezafungin;Expert Review of Anti-infective Therapy;2023-08-17